Skip to content

Clinical trials

Completed Lymphoma, Large B-Cell, Diffuse trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Status: Completed Country / region: Australia Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20061
20071
20092
20101
20111
20121
20133
20154
20162
20173
20183
20192
20202
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche4
Novartis Pharmaceuticals4
Celgene2
Epizyme, Inc.2
Incyte Corporation2
Amgen1
Arbeitsgemeinschaft medikamentoese Tumortherapie1
Austin Health1
Bayer1
BeiGene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse30
Lymphoma8
Lymphoma, Follicular8
Lymphoma, Non-Hodgkin8
Recurrence6
Lymphoma, B-Cell5
Burkitt Lymphoma4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Mantle-Cell3

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.